#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dominique Lessard and Dr. Dylan Verden of KIF1A.ORG summarize newly published KIF1A-related research and highlight progress in rare disease research and therapeutic development.
Read More
We’re glad you’re back for another month of KIF1A.ORG announcements! Please mark your calendars for some very important dates! Read this Monthly Momentum update to learn about the upcoming #GivingTuesday movement, our in-person KAND Conference planned for 2023, and how KIF1A data is being used to advance rare disease treatments in an FDA-funded program.
Read More#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dominique Lessard and Dr. Dylan Verden of KIF1A.ORG summarize newly published KIF1A-related research and highlight progress in rare disease research and therapeutic development.
Read More
KIF1A.ORG’s 19th Research Roundtable meeting, “NeuCyte KAND disease modeling drug screening platform,” was presented by Dr. Wayne Poon from NeuCyte. Read on to learn more about how NeuCyte is developing new ways to test therapeutics for KAND.
Read More#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dominique Lessard and Dr. Dylan Verden of KIF1A.ORG summarize newly published KIF1A-related research and highlight progress in rare disease research and therapeutic development.
Read More
Hello KIF1A.ORG Community, Want to know what’s more valuable than money? Data. In rare diseases, data are inherently difficult to collect and analyze. But we rely on data to inform everything from creating better care guidelines to discovering treatments and cures. We can’t treat what we don’t know. Which symptoms do patients experience, and why…
Read More#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dominique Lessard and Dr. Dylan Verden of KIF1A.ORG summarize newly published KIF1A-related research and highlight progress in rare disease research and therapeutic development.
Read More#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dominique Lessard and Dr. Dylan Verden of KIF1A.ORG summarize newly published KIF1A-related research and highlight progress in rare disease research and therapeutic development.
Read More#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dominique Lessard and Dr. Dylan Verden of KIF1A.ORG summarize newly published KIF1A-related research and highlight progress in rare disease research and therapeutic development.
Read More
As this month comes to an end, we look ahead into the last few months of 2022 with hope, enthusiasm, and drive. You can join us by catching up on our mission-focused and community-driven progress right here in this Monthly Momentum. Also, be sure to mark your calendars for 2023’s in-person KAND Family & Scientific…
Read MoreKIF1A.ORG’s 18th Research Roundtable meeting, “The mechanochemistry of bidirectional axonal transport,” was presented by Dr. William Hancock from Pennsylvania State University. Read on to learn more about how the Hancock Lab is advancing our understanding of KIF1A function.
Read More